Sarolta Komlósi, Pál Czobor, István Bitter
Semmelweis Egyetem Pszichiátriai ds Pszichoterápiás Klinika, Budapest.
Neuropsychopharmacol Hung. 2007 Oct;9(3):143-50.
The aim of the present study is to introduce and give an overview of the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) neurocognitive test battery, which has been recently developed in the United States specifically for the assessment of neurocognitive deficits in patients with schizophrenia. The MATRICS test battery consists of 10 individually administered tests to measure cognitive performance in the following 7 domains: speed of processing, attention/vigilance, working memory, verbal learning, visual learning, reasoning and problem solving, and social cognition. Besides giving a detailed description of the test, the authors also aim to point out the advantages and novel features of the test compared to already existing neuropsychological test batteries used to assess cognition in patients with schizophrenia. The future applicability of the MATRICS test battery will be related to current trends in clinical trials and pharmacological studies. The significance of the standardization and adaptation of the test to Hungarian is emphasized and future possibilities of applying the test in a Hungarian language environment discussed.
本研究的目的是介绍并概述精神分裂症认知改善测量与治疗研究（MATRICS）神经认知测试组，该测试组最近在美国专门为评估精神分裂症患者的神经认知缺陷而开发。MATRICS测试组由10项单独进行的测试组成，用于测量以下7个领域的认知表现：处理速度、注意力/警觉性、工作记忆、言语学习、视觉学习、推理与问题解决以及社会认知。除了详细描述该测试外，作者还旨在指出该测试与用于评估精神分裂症患者认知的现有神经心理测试组相比的优势和新颖之处。MATRICS测试组未来的适用性将与临床试验和药理学研究的当前趋势相关。强调了该测试标准化及匈牙利语改编的重要性，并讨论了在匈牙利语环境中应用该测试的未来可能性。
